Lauri E. Markowitz

47.4k total citations · 33 hit papers
383 papers, 32.5k citations indexed

About

Lauri E. Markowitz is a scholar working on Epidemiology, Surgery and Health. According to data from OpenAlex, Lauri E. Markowitz has authored 383 papers receiving a total of 32.5k indexed citations (citations by other indexed papers that have themselves been cited), including 315 papers in Epidemiology, 122 papers in Surgery and 84 papers in Health. Recurrent topics in Lauri E. Markowitz's work include Cervical Cancer and HPV Research (224 papers), Hepatitis B Virus Studies (157 papers) and Genital Health and Disease (118 papers). Lauri E. Markowitz is often cited by papers focused on Cervical Cancer and HPV Research (224 papers), Hepatitis B Virus Studies (157 papers) and Genital Health and Disease (118 papers). Lauri E. Markowitz collaborates with scholars based in United States, Thailand and United Kingdom. Lauri E. Markowitz's co-authors include Eileen F. Dunne, Elizabeth R. Unger, Harrell W. Chesson, Maya Sternberg, Mona Saraiya, David Yankey, Geraldine M. McQuillan, Elissa Meites, Susan Hariri and Laurie D. Elam–Evans and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

Lauri E. Markowitz

377 papers receiving 31.2k citations

Hit Papers

Quadrivalent Human Papill... 2006 2026 2012 2019 2007 2007 2015 2013 2006 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    2007 1.5k citations Lauri E. Markowitz, Eileen F. Dunne et al. profile →
  2. Prevalence of HPV Infection Among Females in the United States
    2007 1.2k citations Eileen F. Dunne, Elizabeth R. Unger et al. profile →
  3. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.
    2015 808 citations Emiko Petrosky, Susan Hariri et al. PubMed profile →
  4. Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels
    2013 776 citations Ahmedin Jemal, Edgar P. Simard et al. JNCI Journal of the National Cancer Institute profile →
  5. Trends in Herpes Simplex Virus Type 1 and Type 2 Seroprevalence in the United States
    2006 746 citations Fujie Xu, Maya Sternberg et al. profile →
  6. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014
    2015 698 citations David Yankey, Jenny Jeyarajah et al. MMWR Morbidity and Mortality Weekly Report profile →
  7. Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
    2019 671 citations Elissa Meites, Peter G. Szilagyi et al. MMWR Morbidity and Mortality Weekly Report profile →
  8. ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES
    2006 648 citations Harrell W. Chesson, Lauri E. Markowitz et al. profile →
  9. Human Papillomavirus–Associated Cancers — United States, 2008–2012
    2016 624 citations S. Jane Henley, Meg Watson et al. MMWR Morbidity and Mortality Weekly Report profile →
  10. Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices
    2016 621 citations Elissa Meites, Lauri E. Markowitz et al. MMWR Morbidity and Mortality Weekly Report profile →
  11. The Prevalence of Bacterial Vaginosis in the United States, 2001–2004; Associations With Symptoms, Sexual Behaviors, and Reproductive Health
    2007 545 citations Emilia H. Koumans, Maya Sternberg et al. Sexually Transmitted Diseases profile →
  12. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.
    2014 447 citations Shannon Stokley, Jenny Jeyarajah et al. PubMed profile →
  13. The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States
    2014 429 citations Harrell W. Chesson, Eileen F. Dunne et al. Sexually Transmitted Diseases profile →
  14. Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010
    2013 397 citations Lauri E. Markowitz, Susan Hariri et al. profile →
  15. Surveillance of Vaccination Coverage Among Adult Populations — United States, 2014
    2016 375 citations Walter W. Williams, Peng-Jun Lu et al. PubMed profile →
  16. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
    2021 371 citations Julia W. Gargano, Julianne Gee et al. MMWR Morbidity and Mortality Weekly Report profile →
  17. Trends in Human Papillomavirus–Associated Cancers — United States, 1999–2015
    2018 361 citations S. Jane Henley, Mona Saraiya et al. MMWR Morbidity and Mortality Weekly Report profile →
  18. Surveillance of Vaccination Coverage among Adult Populations — United States, 2015
    2017 345 citations Walter W. Williams, Peng-Jun Lu et al. PubMed profile →
  19. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2017
    2018 331 citations Laurie D. Elam–Evans, David Yankey et al. MMWR Morbidity and Mortality Weekly Report profile →
  20. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2016
    2017 319 citations Laurie D. Elam–Evans, James A. Singleton et al. MMWR Morbidity and Mortality Weekly Report profile →
  21. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2018
    2019 302 citations Laurie D. Elam–Evans, David Yankey et al. MMWR Morbidity and Mortality Weekly Report profile →
  22. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2019
    2020 299 citations Laurie D. Elam–Evans, David Yankey et al. MMWR Morbidity and Mortality Weekly Report profile →
  23. Human Papillomavirus–Attributable Cancers — United States, 2012–2016
    2019 295 citations S. Jane Henley, Lauri E. Markowitz et al. MMWR Morbidity and Mortality Weekly Report profile →
  24. Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2018
    2021 288 citations Julia W. Gargano, Rayleen M. Lewis et al. Sexually Transmitted Diseases profile →
  25. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2015
    2016 287 citations David Yankey, Jenny Jeyarajah et al. MMWR Morbidity and Mortality Weekly Report profile →
  26. First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021
    2021 275 citations Julianne Gee, Lauri E. Markowitz et al. MMWR Morbidity and Mortality Weekly Report profile →
  27. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2020
    2021 234 citations Cassandra Pingali, David Yankey et al. MMWR Morbidity and Mortality Weekly Report profile →
  28. Surveillance of Vaccination Coverage Among Adult Populations —United States, 2018
    2021 220 citations Peng-Jun Lu, Lauri E. Markowitz et al. PubMed profile →
  29. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis
    2023 142 citations Lauri E. Markowitz et al. profile →
  30. National Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey-Teen, United States, 2021
    2022 134 citations Cassandra Pingali, David Yankey et al. MMWR Morbidity and Mortality Weekly Report profile →
  31. Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey–Teen, United States, 2022
    2023 127 citations Cassandra Pingali, David Yankey et al. MMWR Morbidity and Mortality Weekly Report profile →
  32. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe
    2022 116 citations Hannah G. Rosenblum, Julianne Gee et al. profile →
  33. National Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey-Teen, United States, 2023
    2024 37 citations Cassandra Pingali, David Yankey et al. MMWR Morbidity and Mortality Weekly Report profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lauri E. Markowitz 23.8k 8.7k 8.0k 5.0k 4.0k 383 32.5k
Suzanne M. Garland 12.5k 0.5× 1.3k 0.2× 5.9k 0.7× 5.6k 1.1× 1.3k 0.3× 569 18.9k
Jennifer S. Smith 15.3k 0.6× 1.9k 0.2× 7.0k 0.9× 3.0k 0.6× 795 0.2× 340 18.8k
F. Xavier Bosch 33.5k 1.4× 1.3k 0.1× 15.3k 1.9× 4.4k 0.9× 862 0.2× 298 44.4k
Helen A. Weiss 6.8k 0.3× 910 0.1× 2.6k 0.3× 2.6k 0.5× 5.0k 1.2× 456 21.3k
Christopher K. Fairley 11.1k 0.5× 779 0.1× 4.4k 0.5× 10.4k 2.1× 5.8k 1.5× 961 24.0k
Laura A. Koutsky 13.6k 0.6× 876 0.1× 6.3k 0.8× 2.9k 0.6× 1.0k 0.3× 173 16.6k
Arthur Reingold 17.8k 0.7× 1.3k 0.1× 2.0k 0.2× 6.2k 1.2× 8.2k 2.0× 300 27.7k
Anna R. Giuliano 12.7k 0.5× 1.5k 0.2× 7.6k 0.9× 1.1k 0.2× 480 0.1× 482 19.0k
Richard Hayes 10.1k 0.4× 1.0k 0.1× 3.0k 0.4× 4.1k 0.8× 12.2k 3.0× 556 28.1k
King K. Holmes 17.7k 0.7× 554 0.1× 5.0k 0.6× 17.0k 3.4× 7.5k 1.9× 470 36.8k

Countries citing papers authored by Lauri E. Markowitz

Since Specialization
Citations

This map shows the geographic impact of Lauri E. Markowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauri E. Markowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauri E. Markowitz more than expected).

Fields of papers citing papers by Lauri E. Markowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauri E. Markowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauri E. Markowitz. The network helps show where Lauri E. Markowitz may publish in the future.

Co-authorship network of co-authors of Lauri E. Markowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Lauri E. Markowitz. A scholar is included among the top collaborators of Lauri E. Markowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauri E. Markowitz. Lauri E. Markowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pingali, Cassandra, David Yankey, Laurie D. Elam–Evans, et al.. (2025). Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey-Teen, United States, 2024. MMWR Morbidity and Mortality Weekly Report. 74(30). 466–472. 7 indexed citations
2.
Clay, P. A., Trevor Thompson, Lauri E. Markowitz, et al.. (2023). Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United States. Vaccine. 41(14). 2376–2381. 12 indexed citations
3.
Rosenblum, Hannah G., Rayleen M. Lewis, Julia W. Gargano, et al.. (2022). Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018. Annals of Internal Medicine. 175(7). 918–926. 40 indexed citations
4.
Gargano, Julia W., Nancy McClung, Rayleen M. Lewis, et al.. (2022). HPV type‐specific trends in cervical precancers in the United States, 2008 to 2016. International Journal of Cancer. 152(2). 137–150. 19 indexed citations
5.
Rosenblum, Hannah G., Rayleen M. Lewis, Julia W. Gargano, et al.. (2021). Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine — United States, 2003–2018. MMWR Morbidity and Mortality Weekly Report. 70(12). 415–420. 72 indexed citations
6.
Meites, Elissa, Peter G. Szilagyi, Harrell W. Chesson, et al.. (2019). Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morbidity and Mortality Weekly Report. 68(32). 698–702. 671 indexed citations breakdown →
7.
Markowitz, Lauri E., Liu Gui, Susan Hariri, et al.. (2016). Prevalence of HPV After Introduction of the Vaccination Program in the United States. PEDIATRICS. 137(3). e20151968–e20151968. 257 indexed citations
8.
Chesson, Harrell W., Lauri E. Markowitz, Susan Hariri, Donatus U. Ekwueme, & Mona Saraiya. (2016). The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model. Human Vaccines & Immunotherapeutics. 12(6). 1363–1372. 37 indexed citations
9.
Petrosky, Emiko, Robyn Neblett Fanfair, Malini B. DeSilva, et al.. (2016). Early Syphilis Among Men Who Have Sex with Men in the US Pacific Northwest, 2008–2013: Clinical Management and Implications for Prevention. AIDS Patient Care and STDs. 30(3). 134–140. 5 indexed citations
10.
Williams, Walter W., Peng-Jun Lu, Alissa O’Halloran, et al.. (2015). Vaccination coverage among adults, excluding influenza vaccination - United States, 2013.. PubMed. 64(4). 95–102. 153 indexed citations
11.
Hariri, Susan, Elizabeth R. Unger, Sean Schafer, et al.. (2014). HPV Type Attribution in High-Grade Cervical Lesions: Assessing the Potential Benefits of Vaccines in a Population-Based Evaluation in the United States. Cancer Epidemiology Biomarkers & Prevention. 24(2). 393–399. 39 indexed citations
12.
Stokley, Shannon, Jenny Jeyarajah, David Yankey, et al.. (2014). Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014--United States.. PubMed. 63(29). 620–4. 447 indexed citations breakdown →
13.
14.
Jemal, Ahmedin, Edgar P. Simard, Christina Dorell, et al.. (2013). Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels. JNCI Journal of the National Cancer Institute. 105(3). 175–201. 776 indexed citations breakdown →
15.
Meites, Elissa, Eloisa Llata, Susan Hariri, et al.. (2011). HPV Vaccine Implementation in STD Clinics—STD Surveillance Network. Sexually Transmitted Diseases. 39(1). 32–34. 10 indexed citations
16.
Dorell, Christina, Shannon Stokley, David Yankey, Amanda Cohn, & Lauri E. Markowitz. (2010). National, state, and local area vaccination coverage among adolescents aged 13-17 years - United States, 2009.. MMWR Morbidity and Mortality Weekly Report. 59(32). 1018–1023. 246 indexed citations
17.
Forhan, Sara E., Sami L. Gottlieb, Maya Sternberg, et al.. (2009). Prevalence of Sexually Transmitted Infections Among Female Adolescents Aged 14 to 19 in the United States. PEDIATRICS. 124(6). 1505–1512. 325 indexed citations
18.
Koumans, Emilia H., et al.. (2001). Sexually transmitted diseases during pregnancy: screening, diagnostic, and treatment practices among prenatal care providers in Georgia.. PubMed. 94(1). 47–53. 18 indexed citations
19.
Polonis, Victoria R., Mark de Souza, Penprapa Chanbancherd, et al.. (2001). HIV Type 1 Subtype E-Infected Patients with Broadened, Dual (B/E) V3 Loop Serology Have Increased Cross-Neutralizing Antibodies. AIDS Research and Human Retroviruses. 17(1). 69–79. 10 indexed citations
20.
Souza, Mark de, Chitraporn Karnasuta, Arthur E. Brown, et al.. (2000). A Comparative Study of the Impact of HIV Infection on Natural Killer Cell Number and Function in Thais and North Americans. AIDS Research and Human Retroviruses. 16(11). 1061–1066. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suzanne M. Garland Breakdown of academic impact, for papers by Jennifer S. Smith Breakdown of academic impact, for papers by F. Xavier Bosch Breakdown of academic impact, for papers by Helen A. Weiss Breakdown of academic impact, for papers by Christopher K. Fairley Breakdown of academic impact, for papers by Laura A. Koutsky Breakdown of academic impact, for papers by Arthur Reingold Breakdown of academic impact, for papers by Anna R. Giuliano Breakdown of academic impact, for papers by Richard Hayes Breakdown of academic impact, for papers by King K. Holmes
Rankless by CCL
2026